BrainAurora Medical Technology Limited 的關鍵財務報表是什麼?
06681.HK 的關鍵財務比率是什麼?
BrainAurora Medical Technology Limited 的收入按細分市場或地理位置如何劃分?
BrainAurora Medical Technology Limited 是否盈利?
BrainAurora Medical Technology Limited 有負債嗎?
BrainAurora Medical Technology Limited 的流通股有多少?
關鍵數據
前收市價
$6.47
開盤價
$6.48
當日範圍
$6.38 - $6.62
52週區間
$3.13 - $17.79
交易量
18.4M
平均成交量
17.5M
每股盈餘 (TTM)
-0.18
股息收益率
--
市值
$8.0B
什麼是 BRAINAURORA-B?
Brainaurora Medical Technology Ltd. engages in research and development of medical-grade cognitive impairment digital therapeutics (DTx) products. The company is headquartered in Shaoxing, Zhejiang and currently employs 174 full-time employees. The company went IPO on 2025-01-08. The firm's main business is engaged in offering the system integral software solutions to hospitals which enables the hospitals to offer assessment and intervention to their cognitive impairment patients. The firm is also engaged in offering research projects services as well as technical and operational support services. The firm's main product is Brain Function Information Management Platform Software System, which enables clinical assessment and interventions for various types of cognitive impairment induced by vascular diseases, neurodegenerative diseases, psychological disorders and child development deficiencies, among other types of cognitive impairments. The firm mainly conducts its business in the domestic market.